NASDAQ:MBX MBX Biosciences (MBX) Stock Price, News & Analysis $49.55 -3.86 (-7.23%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$48.19 -1.36 (-2.75%) As of 11/20/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About MBX Biosciences Stock (NASDAQ:MBX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MBX Biosciences alerts:Sign Up Key Stats Today's Range$49.36▼$54.4350-Day Range$48.46▼$63.8952-Week Range$26.00▼$72.64Volume581,888 shsAverage Volume531,052 shsMarket Capitalization$2.46 billionP/E RatioN/ADividend YieldN/APrice Target$87.30Consensus RatingModerate Buy Company Overview MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company developing peptide-based treatments for endocrine and metabolic disorders. The company’s research focuses on conditions in which naturally occurring hormones are deficient or do not function adequately. MBX uses its Precision Endocrine Peptide (PEP) platform to design peptide medicines intended to provide more durable hormone activity. Its lead candidate, MBX 2109, is being developed as a long-acting parathyroid hormone replacement therapy for people with chronic hypoparathyroidism. Based in Carmel, Indiana, MBX Biosciences is advancing a pipeline of investigational therapies. Its candidates are not approved for commercial use.AI Generated. May Contain Errors. Read More MBX Biosciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreMBX MarketRank™: 3.13210424175 of 5 starsMBX Biosciences scored higher than 63% of companies evaluated by MarketBeat, and ranked 296th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingMBX Biosciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 1 strong buy rating, 11 buy ratings, no hold ratings, and 2 sell ratings.Upside PotentialMBX Biosciences has a consensus price target of $87.30, representing about 76.2% upside from its current price of $49.55.Amount of Analyst CoverageMBX Biosciences has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about MBX Biosciences' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for MBX Biosciences are expected to decrease in the coming year, from ($3.40) to ($4.20) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MBX Biosciences is -16.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MBX Biosciences is -16.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMBX Biosciences has a P/B Ratio of 5.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.91% of the float of MBX Biosciences has been sold short.Short Interest Ratio / Days to CoverMBX Biosciences has a short interest ratio ("days to cover") of 7.9.Change versus previous monthShort interest in MBX Biosciences has recently decreased by 3.11%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMBX Biosciences does not currently pay a dividend.Dividend GrowthMBX Biosciences does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.95 News SentimentMBX Biosciences has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 12 news articles for MBX Biosciences this week, compared to 3 articles on an average week.Search Interest4 people have searched for MBX on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, MBX Biosciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $288,361.00 in company stock.Percentage Held by Insiders31.09% of the stock of MBX Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsMBX Biosciences has minimal institutional ownership at this time.Read more about MBX Biosciences' insider trading history. Receive MBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MBX Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBX Stock News HeadlinesMBX Biosciences (MBX) Stock Looks Above Fair Value On Phase 3 ProgressNovember 19 at 8:48 AM | uk.finance.yahoo.comBrokers Issue Forecasts for MBX Biosciences FY2026 EarningsNovember 16, 2026 | americanbankingnews.comGet your evenings backThe Instant Scanner delivers the night's qualifying setups with exact buy prices and defined exits, in minutes. No hours of flipping through charts, no second-guessing patterns. It's built for traders who want the result without the ritual: a short list and your evening back. Black Friday price is $7 versus the regular $247. One payment covers a full year, with no re-bills.November 21 at 1:00 AM | Profits Run (Ad)MBX Biosciences (NASDAQ:MBX) Stock: Insider Steven Hoerter Sells 4,893 SharesNovember 15, 2026 | americanbankingnews.comMBX Biosciences, Inc. (MBX) Receives a Buy from OppenheimerNovember 13, 2026 | theglobeandmail.comMBX Biosciences, Inc. (MBX) Receives a Buy from OppenheimerNovember 13, 2026 | theglobeandmail.comMBX Biosciences (NASDAQ:MBX) CEO Sells 4,893 Shares of StockNovember 13, 2026 | insidertrades.comInsider Selling: MBX Biosciences (NASDAQ:MBX) Insider Sells 373 Shares of StockNovember 6, 2026 | insidertrades.comSee More Headlines MBX Stock Analysis - Frequently Asked Questions How have MBX shares performed this year? MBX Biosciences' stock was trading at $31.54 at the start of the year. Since then, MBX stock has increased by 57.1% and is now trading at $49.55. How were MBX Biosciences' earnings last quarter? MBX Biosciences, Inc. (NASDAQ:MBX) released its quarterly earnings data on Monday, November, 9th. The company reported ($1.29) EPS for the quarter, missing analysts' consensus estimates of ($0.80) by $0.49. When did MBX Biosciences IPO? MBX Biosciences (MBX) raised $153 million in an initial public offering on Thursday, September 12th 2024. The company issued 10,200,000 shares at $14.00-$16.00 per share. Who are MBX Biosciences' major shareholders? MBX Biosciences' top institutional shareholders include State Street Corp (1.73%), Goldman Sachs Group Inc. (0.86%), Candriam S.C.A. (0.58%) and Soleus Capital Management L.P. (0.52%). Insiders that own company stock include Patrick J Heron, Life Sciences X LP Frazier, Edward T Mathers, Carl L Gordon, P Kent Hawryluk, Steven L Hoerter, Ora H Pescovitz and Salomon Azoulay. View institutional ownership trends. How do I buy shares of MBX Biosciences? Shares of MBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MBX Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that MBX Biosciences investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Strive (ASST), AST SpaceMobile (ASTS), Celldex Therapeutics (CLDX), Definium Therapeutics (DFTX) and Bloom Energy (BE). Company Calendar Last Earnings11/09/2026Today11/21/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (14m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 MBX's financial health is in the Green zone, according to TradeSmith. MBX has been in this zone for over 14 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:MBX Previous SymbolNASDAQ:MBX CIK1776111 Webmbxbio.com Phone(317) 989-3100FaxN/AEmployees63Year Founded2018Price Target and Rating Average Price Target for MBX Biosciences$87.30 High Price Target$150.00 Low Price Target$18.00 Potential Upside/Downside+76.2%Consensus RatingModerate Buy Rating Score (0-4)2.79 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)($3.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$86.97 million Net MarginsN/A Pretax MarginN/A Return on Equity-34.37% Return on Assets-32.72% Debt Debt-to-Equity RatioN/A Current Ratio19.58 Quick Ratio19.58 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$9.52 per share Price / Book5.20Miscellaneous Outstanding Shares49,660,000Free Float34,218,000Market Cap$2.46 billion OptionableOptionable Beta0.17 Social Links 7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and GoogleCould the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.Get This Free Report This page (NASDAQ:MBX) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.